Navigation Links
ePharmaSolutions Launches New Application to Streamline Single Sign-On and User Account Provisioning for Sponsors Using Multiple Clinical Trial Technologies

CONSHOHOCKEN, Pa., April 12, 2011 /PRNewswire/ -- One of the more cumbersome tasks for study teams is to manage the user administration and provisioning process into all of the technologies used to conduct clinical trials today.  ePharmaSolutions has developed an innovative solution to streamline this process to one set of credentials and one technology solution regardless of the number of vendors involved in a given study.

"The Vendor Integration Manager (VIM) is now being used on dozens of studies in more than 60 countries and provides study teams with a single user interface to manage the user provisioning process for almost every vendor involved in clinical trials today," stated Lance Converse, ePharmaSolutions founder and CEO.  "Our clients complained about the need to complete up to 10 different spreadsheets each time a user is added or edited through the study, which on large studies is a difficult task that is ridden with errors," Converse added.

A typical clinical study can require up to 10 unique technology vendors that each has their own account activation and user provisioning forms and processes.  This is cumbersome for clinical study managers conducting large studies who are required to complete these forms each time a user is added or edited throughout a study.  For larger studies, access control to as many as 4,000 unique users in 10 systems with different roles and naming conventions must be maintained and updated in a validated environment.

"The Vendor Integration Manager works as the system of record for each user in the study and auto-completes each leading technology vendor's user account provisioning forms in the exact format and process they require saving study teams an enormous amount of time and avoiding countless mistakes," Converse continued.  "We have 220,000 active users in our system, each with a unique user credential; the VIM is one step closer to our goal of providing single sign-on solutions for the entire clinical research industry."   For a short demonstration of the VIM, go to or stop by booth 331 at the Bio-IT Conference April 12th through April 14th 2011.

About ePharmaSolutions

ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.   ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 220,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in London. For more information visit or call 610-832-9915.  Follow us on LinkedIn and Facebook.

SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mylan Launches Generic Version of Sandostatin®
2. Rules-Based Medicine Launches OncologyMAP® to Advance Cancer-Related Drug and Diagnostic Development
3. Finesse Launches the VirtualTransmitter Module and TruFluor Transmitter Blades for Seamless Integration of Single-Use Sensors Into Bioreactor Control
4. Intrasphere Technologies Launches SafetyXpress(TM) for Oracle(R) Argus Safety
5. Sigma® Life Science Launches Suite of Knockout Rats to Model Parkinsons Disease
6. M-3 Information, a Leader in Expert Behavioral Health Solutions, Launches
7. Sigma® Life Science Launches Pre-designed CompoZr® Knockout Zinc Finger Nucleases for Entire Human Genome
8. MO BIO Laboratories, Inc. Launches Dye Dots™ Dry Gel Loading Dye
9. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
10. Tufts Launches Institute for Biopharmaceutical Partnerships
11. MediVet-America, Leading Animal Stem Cell Developer, Launches MediVet Lab Services
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:6/16/2016)... 2016 The global ... reach USD 1.83 billion by 2024, according to ... Technological proliferation and increasing demand in commercial buildings, ... drive the market growth.      (Logo: ... development of advanced multimodal techniques for biometric authentication ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
Breaking Biology News(10 mins):